DOV vs RANI · P/E 27, rev $4.24B vs rev $3.4M
Dover Corporation (DOV) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. RANI currently screens at market cap $41.5M.
Not investment advice. Open the DOV and RANI stock pages for the full models.
Not investment advice.